Inpatient Management of Inflammatory Bowel Disease-Related Complications
- PMID: 31927105
- DOI: 10.1016/j.cgh.2019.12.040
Inpatient Management of Inflammatory Bowel Disease-Related Complications
Abstract
Despite advances in therapeutic options, a sizeable proportion of patients with inflammatory bowel disease require hospitalization or surgery during their lifetime. While current treatment guidelines for the management of ulcerative colitis and Crohn's disease cover the spectrum of disease severity and behavior, management of acute complications of inflammatory bowel disease can present unique challenges that are not always addressed in these guidelines. In this review, the authors provide a comprehensive summary of the existing literature focused on management of patients hospitalized with complications of inflammatory bowel disease. Proposed management algorithms are provided to guide clinicians through common scenarios to determine the most appropriate interventions - escalation of medical therapies, non-surgical therapeutic interventions (drainage of intra-abdominal abscess or endoscopic balloon dilation) or surgery. Prevention of complications is proposed through a multi-disciplinary approach that involves surgeons, dieticians, radiologists, pathologists and infectious disease consultants.
Keywords: Abscess; Acute Colitis; Hospitalization; IBD; Stricture.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Inflammatory bowel diseases: controversies in the use of diagnostic procedures.Dig Dis. 2009;27(3):269-77. doi: 10.1159/000228560. Epub 2009 Sep 24. Dig Dis. 2009. PMID: 19786751 Review.
-
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460505
-
A comprehensive review and update on Crohn's disease.Dis Mon. 2018 Feb;64(2):20-57. doi: 10.1016/j.disamonth.2017.07.001. Epub 2017 Aug 18. Dis Mon. 2018. PMID: 28826742 Review.
-
Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.Endoscopy. 2009 Jul;41(7):618-37. doi: 10.1055/s-0029-1214790. Epub 2009 Jul 8. Endoscopy. 2009. PMID: 19588292 Review.
-
Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.Dig Liver Dis. 2005 Jun;37(6):407-17. doi: 10.1016/j.dld.2004.12.013. Dig Liver Dis. 2005. PMID: 15893279 Review.
Cited by
-
The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic.Curr Res Pharmacol Drug Discov. 2022;3:100101. doi: 10.1016/j.crphar.2022.100101. Epub 2022 Apr 26. Curr Res Pharmacol Drug Discov. 2022. PMID: 35496814 Free PMC article. Review.
-
Causal Link between Inflammatory Bowel Disease and Fistula: Evidence from Mendelian Randomization Study.J Clin Med. 2023 Mar 24;12(7):2482. doi: 10.3390/jcm12072482. J Clin Med. 2023. PMID: 37048564 Free PMC article.
-
Self-screening questionnaire for perianal fistulizing disease in patients with Crohn's disease.Korean J Intern Med. 2024 May;39(3):430-438. doi: 10.3904/kjim.2023.410. Epub 2024 Apr 5. Korean J Intern Med. 2024. PMID: 38576234 Free PMC article.
-
Amlexanox targeted inhibition of TBK1 regulates immune cell function to exacerbate DSS-induced inflammatory bowel disease.Clin Exp Immunol. 2025 Jan 21;219(1):uxae082. doi: 10.1093/cei/uxae082. Clin Exp Immunol. 2025. PMID: 39248363 Free PMC article.
-
Day-by-Day Management of the Inpatient With Moderate to Severe Inflammatory Bowel Disease.Gastroenterol Hepatol (N Y). 2020 Sep;16(9):449-457. Gastroenterol Hepatol (N Y). 2020. PMID: 34035752 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical